surgical mesh

The Food and Drug Administration (FDA) has stopped Boston Scientific and Coloplast from selling the surgical mesh for the repair of organ prolapse within the United States. Read more

North America

NHS Trusts could face legal action if they do not enforce ‘high vigilance restrictions’ in the use of mesh following new guidance published by the National Institute of Clinical Excellence (NICE). Read more


NICE has released updated guidelines involving the use of surgical mesh products which were previously halted following an independent review. Read more


Becton, Dickson and Company has withdrawn its surgical mesh for stress urinary incontinence (SUI) and pelvic organ prolapse (POP) from hospitals and distribution centres, with the company saying the move is part of its business strategy. Read more